rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TEM
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Tempus AI and AstraZeneca amend agreement with new five-year, $200 million commitment
      12h agoInvesting.comAZNTEM
      Cathie Wood's weekly recap: boosts Nvidia, CoreWeave, Archer Aviation; pares Tempus AI, Palantir

      Ark Invest bought $16.2M of Nvidia and $16.0M of CoreWeave last week, while selling $12.8M of Tempus AI and $9.1M of Block.

      Nov 16Seeking AlphaCRWVTEMACHRPLTR
      Tempus AI And 2 More AI Healthcare Stocks
      Nov 15Yahoo FinanceTEM
      NN, Fluence Energy, GRAIL, Tempus AI, and CSW shares are falling, what you need to know

      Detailed price information for Fluence Energy Inc Cl A (FLNC-Q) from The Globe and Mail including charting and trades.

      Nov 12The Globe and MailFLNCTEM
      The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
      Nov 11Yahoo FinanceTEM
      Tempus AI (TEM) Surged on Data Business Momentum and MRD Testing Expansion
      Nov 10Yahoo FinanceTEM
      Tempus AI Stock: Q3 Strengthens Platform Thesis Cash Returns Need To Catch Up (NASDAQ:TEM)

      Tempus is rated hold as valuation reflects future success.

      Nov 8Seeking AlphaTEM
      Tempus AI Stock: An Inflection Point Has Arrived (Earnings Analysis) (NASDAQ:TEM)

      Tempus AI Q3 results show 23% revenue growth, soaring diagnostics, and key pharma partnerships. Read here for more on TEM stock.

      Nov 4Seeking AlphaTEM
      TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside
      Nov 3Yahoo FinanceTEM
      H.C. Wainwright raises Tempus AI stock price target to $85 on valuation
      Nov 3Investing.comTEM
      Why Tempus AI Stock Is Up 8.7% And What's Next
      Nov 3Yahoo FinanceTEM
      Tempus AI Analysts Boost Their Forecasts Following Strong Q3 Results
      Nov 3BenzingaTEM
      Tempus AI (TEM) Stock Looks Fully Priced Following Its 26% Run

      Tempus AI has delivered a strong year to date gain, and a stream of new partnerships and regulatory milestones has helped keep the stock in focus. With the share price moving faster than many investors can track the underlying business, the key issue now is whether Tempus AI's current market value is still grounded in its sales. Year to date, the stock is up 25.8%, which puts real pressure on the question of whether recent top line performance can support that kind of re-rating based on...

      Nov 3Yahoo FinanceTEM
      BTIG raises Tempus AI stock price target to $100 on data deals
      Nov 3Investing.comTEM
      Jefferies upgrades Tempus AI stock rating to hold, raises price target to $70
      Nov 3Investing.comTEM
      Tempus AI Inc (TEM) Q3 2026 Earnings Call Highlights: Revenue Jumps 23% to $411. ...
      Nov 3Yahoo FinanceTEM
      Do You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge
      Nov 2Yahoo FinanceTEM
      Stocks making the biggest moves midday: Oracle, SpaceX, Tempus AI, Rivian & more

      These are some of the stocks posting the largest moves midday.

      Nov 2CNBCRIVNSPCXTEMORCL
      Tempus AI, Inc. Q3 2026 Earnings Call Summary

      Moby summary of Tempus AI, Inc.'s Q3 2026 earnings call

      Nov 2Yahoo FinanceTEM
      Tempus AI Says It Is Uniquely Positioned
      Nov 2BenzingaTEM
      Needham raises Tempus AI stock price target to $89 on data growth
      Nov 2Investing.comTEM
      What Tempus AI (TEM) Said on Its Q3 Earnings Call
      Nov 2Yahoo FinanceTEM
      Tempus AI Revenue Up 23%; Gains Cut Net Loss: Rapid Earnings Reaction | The Motley Fool

      Tempus AI raised its outlook on 23% revenue growth, but most of its smaller net loss came from paper gains on stock it holds, not the core business.

      Nov 2The Motley FoolTEM
      Tempus AI shares jump as Q3 revenue beats expectations and company raises full-year outlook

      Tempus AI (NASDAQ:TEM) shares climbed almost 10% on Monday after the healthcare technology company reported third-quarter revenue and adjusted earnings ahead of Wall Street expectations, while raising its full-year guidance. The company generated revenue of US$411.5 million in the third...

      Nov 2Yahoo FinanceTEM
      Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say
      Nov 2Yahoo FinanceTEM
      Tempus AI (TEM) Beats Q3 Earnings and Revenue Estimates
      Nov 2Yahoo FinanceTEM
      Tempus Q3 2026 slides: first positive EBITDA, 23% revenue growth
      Nov 2Investing.comTEM
      Earnings call transcript: Tempus AI beats Q3 2026 EPS forecast, lifts outlook
      Nov 2Investing.comTEM
      Tempus AI Shares Rise 4.18% as Q3 Earnings Beat Forecasts and Revenue Guidance Increases
      Nov 2Yahoo FinanceTEM
      Why is Tempus AI stock rallying today?
      Nov 2Investing.comTEM
      Tempus AI’s Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer

      Tempus AI reported better-than-expected third-quarter earnings.

      Nov 2Barron'sTEM
      Tempus: Q3 Earnings Snapshot
      Nov 2Yahoo FinanceTEM
      Tempus AI shares rise 4% on earnings beat and raised guidance
      Nov 2Investing.comTEM
      Tempus AI faces profitability test as earnings loom Monday
      Nov 2Investing.comTEM
      Tempus AI Earnings Ahead: Is TEM Set Up To Pop or Drop?
      Nov 1BenzingaTEM
      Cathie Wood buys $11.2 million of popular AI stock
      Nov 1TheStreetTEM
      Cathie Wood’s ARK sells Eli Lilly stock, buys Tempus AI and Coinbase
      Oct 31Investing.comCOINTEMLLY
      Cathie Wood’s ARK sees strong interest in Cerebras stock, trims Tempus AI
      Oct 30Investing.comCBRSTEM
      This Stock Offers Juicy Option Premiums, But Also Is Highly Risky

      Implied volatility currently sits at 87%, close to the highest levels for Tempus AI stock in the last 12 months.

      Oct 29Investor's Business DailyTEM
      Tempus AI (TEM) Could Be 5% Undervalued After Bristol Myers And Pathos Deals
      Oct 27Yahoo FinanceTEMBMY
      The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings
      Oct 27Yahoo FinancePSNLTEM
      Tempus AI stock may move 8.7% on Nov. 2 earnings report
      Oct 26Investing.comTEM
      Tempus AI (TEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
      Oct 26Yahoo FinanceTEM
      Tempus AI receives EU certification for cancer genomic test
      Oct 26Investing.comTEM
      Tempus AI stock price target raised to $68 by H.C. Wainwright
      Oct 26Investing.comTEM
      How Tempus AI (TEM) Built A Defensible Data Moat In Precision Healthcare

      Tempus AI sits at the intersection of AI infra and clinical diagnostics. It's a holding in both the ROBO Global Artificial Intelligence ETF and the ROBO Global Healthcare and Innovation ETF.

      Oct 24Seeking AlphaTEMHTECTHNQ
      Bristol, Tempus AI partnering with Pathos AI to advance neurological treatments

      Bristol Myers Squibb and Tempus AI partner with Pathos AI to advance Alzheimer’s research with AI-driven datasets and smarter trials. Read more here.

      Oct 23Seeking AlphaTEMBMY
      Tempus AI Gains 6% as Bristol Myers Squibb Licenses Oncology Data
      Oct 23Yahoo FinanceTEMBMY
      Tempus AI: Less Risky Than When I Said Buy (NASDAQ:TEM)
      Oct 23Seeking AlphaTEM
      Tempus AI enters data licensing agreements with BMS and Pathos AI worth $192.5 million
      Oct 23Investing.comTEM

      This is the newest page. Registered accounts read further back.